☆ 3.8 Editorial Material

Sertoli-Leydig cell tumor associated with a germline DICER1 pathogenic variant diagnosed during pregnancy: Considerations for treatment, surveillance, and prevention

GYNECOLOGIC ONCOLOGY REPORTS (2023)

Journal

GYNECOLOGIC ONCOLOGY REPORTS

Volume 48, Issue -, Pages -

Publisher

ELSEVIER SCIENCE INC

DOI: 10.1016/j.gore.2023.101215

Keywords

DICER1; Genetic testing; Metachronous tumor; Post-treatment surveillance; Pregnancy; Sertoli-Leydig cell tumor

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8

Not enough ratings

Sertoli-Leydig cell tumor associated with a germline DICER1 pathogenic variant diagnosed during pregnancy: Considerations for treatment, surveillance, and prevention

Journal

GYNECOLOGIC ONCOLOGY REPORTS

Publisher

ELSEVIER SCIENCE INC

Keywords

Categories

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Sertoli-Leydig cell tumor associated with a germline DICER1 pathogenic variant diagnosed during pregnancy: Considerations for treatment, surveillance, and prevention

Journal

GYNECOLOGIC ONCOLOGY REPORTS

Publisher

ELSEVIER SCIENCE INC

Keywords

Categories

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper